Oncolytic Virus Therapy Market to Grow at CAGR of 20.3% through 2027 | Industry Dynamics and Competitor Breakdown

Spread the love

Report Overview:

The following report titled “Global Oncolytic Virus Therapy MarketTherapy (IMLYGIC (Talimogene Laherparepvec), Oncorine, RIGVIR Immunotherapy, Onyx-15, and Reolysin), By Application (Solid Tumor (Breast Cancer, Prostate Cancer, Lung Cancer, Glioblastoma/Glioblastoma Multiforme), Melanoma, and Hematological Malignancies (Lymphoma, Leukemia, and Myeloma)) and other forecast 2022-2027” provides a comprehensive analysis of the market, focusing on key details such as market size, growth trends, determinants of growth, segments covered, and the role of leading players in the industry.

Global Oncolytic Virus Therapy Market Summary

According to MarkNtel Advisors, the Global Oncolytic Virus Therapy Market is projected to grow at a CAGR of around 20.3% during the forecast period i.e. 2022-27. The market is driven primarily by the mounting prevalence of cancer worldwide and the surging number of clinical trials & R&D investments for cancer therapies.

Report Coverage & Details

  • Forecast Period: 2022-2027
  • Base Year: 2021
  • CAGR: 20.3%

“Notice: Our reports are under revision. Click “Download Sample Report’ for the latest data on 2024-2030 forecasts and industry insights. Our team ensures prompt delivery of the updated version.”

Download Free PDF Brochure: –  https://www.marknteladvisors.com/query/request-sample/oncolytic-virus-therapy-market.html

Oncolytic Virus Therapy Market Driver:

  • Increasing technological advancements in cancer treatments & the development of new therapies
  • Growing adoption of advanced therapeutic options & rising cancer cases
  • Research & Development initiatives & investments by healthcare providers.

Segmentation Analysis: Oncolytic Virus Therapy Market

By Therapy

  • IMLYGIC (Talimogene Laherparepvec)
  • Oncorine
  • RIGVIR Immunotherapy
  • Onyx-15
  • Reolysin

By Application

  • Solid Tumor
    • Breast Cancer
    • Prostate Cancer
    • Lung Cancer
    • Glioblastoma/Glioblastoma Multiforme
  • Melanoma
  • Hematological Malignancies
    • Lymphoma
    • Leukemia
    • Myeloma

By Type of Virus

  • Genetically Engineered Oncolytic Virus
    • Herpes Simplex Virus(HSV)
    • Adenovirus
    • Vaccinia Virus
  • Oncolytic Wild Type of Viruses
    • Myxoma
    • Vesicular Stomatitis Virus (VSV)
    • Newcastle Disease Virus (NDV)
    • Reovirus (Respiratory Enteric Orphan Virus)

By End-User

  • Hospitals
  • Clinics
  • Patients
  • Cancer Research Institutes

By Region

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia Pacific

Access Full Report [Include Description + TOC] – https://www.marknteladvisors.com/research-library/oncolytic-virus-therapy-market.html

Region: North America Holds a Major Market Share

Among all regions globally, North America is anticipated to dominate the Oncolytic Virus Therapy Market with the largest share during 2022-27.

Leading Players Analysis: Oncolytic Virus Therapy Market

The report provides detailed analysis of key players in the global Oncolytic Virus Therapy market, highlighting their strategies and competitive scenario.

  • Amgen Inc.
  • Daiichi Sankyo Company Limited
  • DNAtrix
  • Genelux Corporation
  • Oncolytics Biotech Inc.
  • PsiOxus Therapeutics
  • RIGVIR Ltd.
  • Shanghai Sunway Biotech Co. Ltd.
  • SillaJen Inc.
  • Sorrento Therapeutics Inc.
  • Takara Bio Inc.
  • Lokon Pharma AB
  • VCN Biosciences
  • ViroCure Inc.
  • Viralytics Ltd. (Merck & Co. Inc.)

Note: Should you require specific information beyond the current scope of the report, we are prepared to furnish it as part of our customization services.

For Customized Report Inquiry: – https://www.marknteladvisors.com/query/request-customization/oncolytic-virus-therapy-market.html

Key Benefits for Stakeholders:

  1. Informed Decision-Making: Access to comprehensive and insightful market research reports enables stakeholders to make well-informed decisions, leading to more strategic and successful initiatives.
  2. Strategic Planning: The strategic reports provided by MarkNtel Advisors empower stakeholders to formulate robust strategies for market entry, product development, and competitive positioning.
  3. Market Sizing & Forecasting: Stakeholders can benefit from accurate market sizing and forecasting data to make informed investment and resource allocation decisions, minimizing risks and maximizing returns.
  4. Competitive Benchmarking: The availability of competitive benchmarking data allows stakeholders to assess their performance against industry peers, identify areas for improvement, and capitalize on strengths.
  5. Identifying Investment Opportunities: Through trend analysis and industry insights, stakeholders can identify attractive investment opportunities and stay ahead in the market for better ROI.

About us

We are a well-known consulting, data analytics, and market research firm catering to a diverse clientele globally. With a strong presence in over 80 countries across regions like America, Asia-Pacific, Europe, the Middle East, and Africa, we specialize in providing strategic reports to multinational corporations, financial institutions, governments, and individuals. Our commitment to qualitative and quantitative research ensures comprehensive and insightful data delivery, establishing us as a trusted partner for informed decision-making.

Contact Information:

(Visited 9 times, 1 visits today)

Tinggalkan Balasan

Alamat email Anda tidak akan dipublikasikan. Ruas yang wajib ditandai *